Brief: Prometheus Biosciences Announces Pricing Of Public Upsized $500 Million Offering Of Common Stock
Dec 8 (Reuters) - Prometheus Biosciences Inc RXDX.O :
* PROMETHEUS BIOSCIENCES, INC. ANNOUNCES PRICING OF PUBLIC
UPSIZED
$500 MILLION OFFERING OF COMMON STOCK
* PRICING OF AN UNDERWRITTEN OFFERING OF 4.5 MILLION SHARES
OF ITS
COMMON STOCK AT A PRICE TO PUBLIC OF $110 PER SHARE
Source text for Eikon: ID:nGNX8L7ZxH
Further company coverage: RXDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prometheus Biosciences
See all newsBrief: Prometheus Biosciences - Completed Merger Of Splash Merger Sub, Unit Of Merck & Co
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
William Blair sees FTC suit on Amgen-Horizon deal weighing on biotech M&A sentiment
FTC scrutiny to block Amgen-Horizon deal drags down Seagen, Prometheus
Brief: Prometheus Biosciences Reports First Quarter 2023 Financial Results